What prophylactic medications are available for migraine prevention besides topiramate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prophylactic Migraine Medications Other Than Topiramate

For episodic migraine prevention, start with propranolol, metoprolol, or timolol (beta-blockers) as first-line alternatives to topiramate, with amitriptyline or divalproex/valproate as equally effective first-line options. 1

First-Line Alternatives (Episodic Migraine)

The 2025 American College of Physicians guideline establishes clear first-line options beyond topiramate 1:

Beta-Blockers

  • Propranolol, metoprolol, or timolol reduce migraine days by approximately 1.27 days per month compared to placebo 2
  • These are established as effective based on high-quality evidence 1, 3
  • Start low and titrate gradually to therapeutic doses

Antidepressants

  • Amitriptyline reduces migraine days by 1.2 days per month 2
  • Particularly useful in patients with comorbid depression, anxiety, or insomnia 4
  • First-line status supported by multiple guidelines 1, 5

Antiepileptics

  • Divalproex sodium or valproate are first-line alternatives 1, 3
  • Critical caveat: Avoid in people of childbearing potential due to teratogenicity 1
  • Must discuss pregnancy risks before prescribing

Calcium Channel Blockers

  • Flunarizine reduces migraine days by 0.44 days per month 2
  • Recommended as first-line in Taiwan and European guidelines 5
  • Not available in all countries (including the US)

Second-Line Options

When first-line treatments fail or are not tolerated 1:

ACE Inhibitors and ARBs

  • Lisinopril (ACE inhibitor)
  • Candesartan or telmisartan (ARBs)
  • Evidence is limited but these are reasonable alternatives 1, 6

SSRIs

  • Fluoxetine has some supporting evidence 1
  • Less robust data than other first-line agents

Advanced/Specialized Therapies

CGRP Monoclonal Antibodies

For patients who have failed 2-3 oral preventives, CGRP antibodies are highly effective 1, 4:

  • Erenumab: Reduces migraine days by 1.0-2.5 per month 2
  • Fremanezumab: Reduces migraine days by 1.3-3.8 per month 2
  • Galcanezumab: Reduces migraine days by 1.1-3.7 per month 2
  • Eptinezumab: Reduces migraine days by 0.7-3.2 per month 2

These are well-tolerated with minimal side effects and work even in patients who failed multiple oral preventives 2, 5

CGRP Receptor Antagonists (Gepants)

  • Atogepant: Reduces migraine days by 0.7-2.4 per month 2
  • Oral option with similar efficacy to monoclonal antibodies
  • Effective in both episodic and chronic migraine 2

Chronic Migraine Specific Options

For chronic migraine (≥15 headache days/month) 4:

First-Line for Chronic Migraine

  • OnabotulinumtoxinA (Botox): FDA-approved specifically for chronic migraine 4, 5
  • CGRP monoclonal antibodies: Effective even with medication overuse 4, 2
  • Topiramate: Remains an option but you're seeking alternatives
  • Flunarizine: First-line in some guidelines 5

Practical Prescribing Algorithm

  1. Start with oral first-line agents (propranolol, metoprolol, timolol, amitriptyline, or divalproex) 1

    • Initiate at low dose and titrate gradually over 2-3 months 1
    • Use headache diary to track response
  2. If inadequate response after 2-3 months, switch to different first-line agent 1

  3. After failing 2-3 oral preventives, consider:

    • CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) 1, 2
    • Atogepant (oral CGRP antagonist) 2
    • OnabotulinumtoxinA if chronic migraine 4, 5
  4. Match medication to comorbidities 4:

    • Depression/anxiety/insomnia → amitriptyline
    • Hypertension → beta-blockers, ACE inhibitors, or ARBs
    • Obesity → avoid amitriptyline; consider agents with weight loss profile

Critical Caveats

  • Pregnancy/childbearing potential: Avoid valproate entirely; discuss risks of all medications before prescribing 1
  • Medication overuse headache: Must be addressed before preventive therapy can be fully effective 4
  • Cost considerations: Prescribe less costly medications first (oral agents before biologics) 1
  • Combination therapy: Topiramate + amitriptyline shows no added benefit over monotherapy with increased side effects 1
  • Trial duration: Give adequate trial of 2-3 months at therapeutic dose before declaring failure 1, 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.